| ||||
| ||||
BUY | ||||
CMP: Rs293 | Target Price: Rs400 | Click here to download full report | |||
■ JLR's Q1 EBITDA of GBP449mn (-55% qoq) came in 5% below our estimates. Margin contracted 630bps qoq to 9%, mainly due to delayed semiconductor supplies, resulting in negative operating leverage and emission penalties. ■ JLR's order book is strong at 110,000 units, but wholesales are unable to meet demand. Q1 wholesales (ex CJLR) were low at ~84,000 units, and Q2 guidance is lower at ~65,000 units. Management hopes for an improvement to ~90,000 units in Q3 and a further increase in Q4, led by a pick-up in semiconductor supplies. ■ We reduce consolidated EBITDA for FY22E/23E/24E by 16%/4%/2%, mainly due to lower volume and margin assumptions at JLR. Despite the cut in EBITDA, we expect robust revenue/EBITDA CAGRs of 17%/22% over FY21-24E, led by anticipated sales cycle upturns in standalone and JLR divisions. ■ Near-term stock catalysts include better standalone volumes, probable tie-up of JLR with larger OEMs for licensing of EV platform and possibility of partial divestments of India PV division. In addition, JLR's sales upcycle is expected from H2 onward. Retain Buy with SOTP-based TP of Rs400 at 2x/11x EV/EBITDA on Sep'23E (Mar'23E earlier). Please see our sector model portfolio (Emkay Alpha Portfolio): Automobiles & Auto Ancillaries |
To view more Research Reports visit the Emkay Research Portal. |
Comments
Post a Comment